Non-Alcoholic Fatty Liver Disease (NAFLD) is an escalating public health issue, affecting approximately one quarter of the global population. Characterised by excessive fat accumulation in the liver, it ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. This article aims to provide an overview of NAFLD, its causes, diagnosis, and modern treatment approaches.
NAFLD is closely linked with metabolic syndrome, obesity, type 2 diabetes mellitus (T2DM), and dyslipidemia. Genetic predisposition, dietary habits, and sedentary lifestyle are also contributing factors. Notably, NAFLD can occur in individuals with normal body weight, highlighting the influence of metabolic health beyond obesity.
NAFLD diagnosis is often incidental, discovered through abnormal liver function tests or imaging studies. Ultrasonography is the first-line imaging modality, but lacks sensitivity for mild steatosis and cannot assess fibrosis. Liver biopsy remains the gold standard for diagnosis, but its invasive nature limits its use. Non-invasive tests like transient elastography and serum biomarkers are gaining acceptance for initial assessment and monitoring.
Currently, there's no approved pharmacotherapy for NAFLD. Management focuses on lifestyle modifications to reduce weight and improve metabolic health. In patients with NASH and fibrosis, Vitamin E and Pioglitazone have shown some benefits. Several drugs targeting various pathophysiological aspects of NAFLD are under investigation. Bariatric surgery may be considered in morbidly obese patients with NAFLD.
NAFLD is a complex, multifactorial disease with significant health implications. Understanding its causes and diagnostic challenges is crucial for early detection and management. While lifestyle modifications remain the cornerstone of treatment, ongoing research holds promise for more targeted and effective therapies in the future.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation